K. Dheda

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
K Dheda, K. Dheda, Keertan Dheda, Keertan Unkha Jairam Dheda
Publication record
546 papers · 35,765 citations · H-index 90

PAPERS

Tongue swab Mycobacterium tuberculosis qPCR for community screening of asymptomatic TB vs. clinic-based triage of symptomatic TB
20260 citationsauthor #26
Host- and pathogen-related determinants of pulmonary versus extrapulmonary tuberculosis
20260 citationsauthor #6
Treatment Outcomes and Drug-Related Adverse Events Across Four Short-Course RR-TB Regimens in South Africa: A Retrospective Analysis.
20260 citationsauthor #13
Exploring the diagnostic accuracy of an HIV self-test optimized by a digital app-based solution: Results from a secondary data analysis of a field trial in South Africa
20250 citationsauthor #8
VIDAS® TB-IGRA assay for diagnosing tuberculosis infection in people living with HIV: a preliminary study.
20251 citationsauthor #8
Dendritic cells in the lung cavities of extensively drug-resistant tuberculosis patients exhibit altered frequency and phenotype
20250 citationsauthor #6
Inflammatory Biomarkers of Asymptomatic and Symptomatic Tuberculosis
20250 citationsauthor #20
Accuracy of VIDAS® TB-IGRA in TB patients and individuals with different thresholds of exposure.
20251 citationsauthor #46
Reply to Adzemovic et al
20250 citationsauthor #9
How to make an app-based program work and show how it works
20250 citationsauthor #5
Clinical evaluation of computer-aided digital x-ray detection of pulmonary tuberculosis during community-based screening or active case-finding: a case-control study.
20254 citationsauthor #15
Validation and clinical application of an LC-MS/MS method designed to simultaneously measure seven second-line TB drugs and two metabolites in human lung tissue.
20252 citationsauthor #7
Asymptomatic tuberculosis: undetected and underestimated, but not unimportant.
20252 citationsauthor #1
Factors associated with tuberculosis treatment initiation among bacteriologically negative individuals evaluated for tuberculosis: An individual patient data meta-analysis
20253 citationsauthor #7
Autologous Human Dendritic Cells from XDR-TB Patients Polarize a Th1 Response Which Is Bactericidal to Mycobacterium tuberculosis
20250 citationsauthor #7
Clinical standards for antimicrobial stewardship in TB care
20251 citationsauthor #6
Optimal dosing and duration of linezolid for the treatment of multidrug-resistant and rifampicin-resistant tuberculosis: an individual patient data meta-analysis
20254 citationsauthor #8
Integrating molecular and radiological screening tools during community-based active case-finding for tuberculosis and COVID-19 in southern Africa.
20243 citationsauthor #20
VIDAS(R) TB-IGRA accuracy in tuberculosis patients and persons at varying risk of exposure
20241 citationsauthor #47
Factors associated with tuberculosis treatment initiation among bacteriologically negative individuals evaluated for tuberculosis: an individual patient data meta-analysis
20240 citationsauthor #7
Target regimen profiles for tuberculosis treatment
202420 citationsauthor #22
Immunogenicity and safety following a homologous booster dose of a SARS-CoV-2 recombinant spike protein vaccine with Matrix-MTM adjuvant (NVX-CoV2373) versus a primary series in people living with and without HIV-1 infection in South Africa: A randomized crossover phase 2a/2b trial
20242 citationsauthor #16
SARS-CoV-2 Viral Replication Persists in the Human Lung for Several Weeks after Symptom Onset
202410 citationsauthor #36
Towards shorter, safer, flexible, and more effective treatment regimens for drug-resistant tuberculosis.
20243 citationsauthor #1
Diagnostic Performance of Unstimulated IFN-γ (IRISA-TB) for Pleural Tuberculosis: A Prospective Study in South Africa and India
20241 citationsauthor #15
Diagnostic Accuracy of Computer-Aided Detection During Active Case Finding for Pulmonary Tuberculosis in Africa: A Systematic Review and Meta-analysis
202410 citationsauthor #12
Review of Current Tuberculosis Human Infection Studies for Use in Accelerating Tuberculosis Vaccine Development: A Meeting Report
20246 citationsauthor #2
GeneXpert MTB/RIF Ultra vs Unstimulated Interferon γ (IRISA-TB) for the Diagnosis of Tuberculous Pericarditis in a Tuberculosis-Endemic Setting
20241 citationsauthor #7
Breaking the threshold: developing multivariable models using computer-aided chest X-ray analysis for tuberculosis triage.
20243 citationsauthor #4
Revisiting diagnostics: High priority tuberculosis diagnostic tests that fill an unmet need: what we need and what we don't.
20242 citationsauthor #5
Multidrug-resistant tuberculosis
2024142 citationsauthor #1
Design of a Newpleural Biopsy Device for Improved Procedural Efficacy
20240 citationsauthor #2
New framework to define the spectrum of tuberculosis.
20243 citationsauthor #1
Optimal timing to discontinue respiratory isolation among patients with pulmonary TB.
20240 citationsauthor #4
Utility of Cerebrospinal Fluid Unstimulated Interferon-Gamma (IRISA-TB) as a Same-Day Test for Tuberculous Meningitis in a Tuberculosis-Endemic, Resource-Poor Setting
20242 citationsauthor #8
Bedaquiline resistance in patients with drug-resistant tuberculosis in Cape Town, South Africa: a retrospective longitudinal cohort study
202355 citationsauthor #19
Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a 2023 TBnet/RESIST-TB consensus statement.
202347 citationsauthor #7
Novavax NVX-COV2373 triggers neutralization of Omicron sub-lineages
202332 citationsauthor #15
Diagnostic yield of urine lipoarabinomannan and sputum tuberculosis tests in people living with HIV: a systematic review and meta-analysis of individual participant data.
202348 citationsauthor #28
Long-term outcomes of the global tuberculosis and COVID-19 co-infection cohort
202326 citationsauthor #148
OA-208 Evaluating the impact of computer-assisted x-ray diagnosis and other triage tools to optimise Xpert orientated community-based active case finding for TB and COVID-19 (XACT-19)
20230 citationsauthor #13
A comparison of chest radiographic findings in human immunodeficiency virus-positive and -negative children with pulmonary tuberculosis.
20231 citationsauthor #5
1513. Evaluating the Incremental Accuracy of HIV Self-Test Together with an App-Based Solution: A Secondary Data Analysis of Trial Data
20232 citationsauthor #6
SARS-CoV-2 viral replication persists in the human lung for several weeks after onset of symptomatic severe COVID-19 and is associated with attenuated pulmonary immunity and variant-specific clinical sequalae
20231 citationsauthor #36
Variation in missed doses and reasons for discontinuation of anti-tuberculosis drugs during hospital treatment for drug-resistant tuberculosis in South Africa
202311 citationsauthor #4
Recent advances in the treatment of tuberculosis.
202374 citationsauthor #4
Meropenem-vaborbactam restoration of first-line drugs' efficacy and comparison of meropenem-vaborbactam-moxifloxacin versus BPaL MDR-TB regimen.
20232 citationsauthor #6
PA-139 Impact of molecular diagnostic tools for community-based active case-finding: a multicentre randomised controlled trial
20230 citationsauthor #12
Standards for clinical trials for treating TB
20236 citationsauthor #39
Comparison of two diagnostic intervention packages for community-based active case finding for tuberculosis: an open-label randomized controlled trial
202322 citationsauthor #15
Identifying patients with multidrug-resistant tuberculosis who may benefit from shorter durations of treatment
20230 citationsauthor #9
Self-tests for COVID-19: What is the evidence? A living systematic review and meta-analysis (2020–2023)
202316 citationsauthor #7
Development and Evaluation of a Digital HIV Risk Assessment Tool Incorporated Within an App-Based Self-Testing Program
20235 citationsauthor #5
Longitudinal IgA and IgG Response, and ACE2 Binding Blockade, to Full-Length SARS-CoV-2 Spike Protein Variants in a Population of Black PLWH Vaccinated with ChAdOx1 nCoV-19
20231 citationsauthor #12
Efficacy of primary series AZD1222 (ChAdOx1 nCoV-19) vaccination against SARS-CoV-2 variants of concern: Final analysis of a randomized, placebo-controlled, phase 1b/2 study in South African adults (COV005)
20234 citationsauthor #8
ChAdOx1 nCoV-19 (AZD1222) vaccine-induced Fc receptor binding tracks with differential susceptibility to COVID-19
202321 citationsauthor #15
Socioeconomic factors impact the risk of HIV acquisition in the township population of South Africa: A Bayesian analysis
202329 citationsauthor #5
Clinical standards for the management of adverse effects during treatment for TB
202331 citationsauthor #21
DIFFERENTIATION OF COMMON GENITAL ULCER DISEASE PATHOGENS USING SEQUENTIAL OR PARALLEL MOLECULAR TESTING
20230 citationsauthor #9
Proteomic Profiling of Urine From Hospitalized Patients With Severe Pneumonia due to SARS-CoV-2 vs Other Causes: A Preliminary Report
20232 citationsauthor #11
Macrolides for better resolution of community-acquired pneumonia: A global meta-analysis of clinical outcomes with focus on microbial etiology.
202311 citationsauthor #6
Updating the approaches to define susceptibility and resistance to anti-tuberculosis agents: implications for diagnosis and treatment
202228 citationsauthor #26
Novel tuberculosis combination regimens of two and three-months therapy duration
20226 citationsauthor #8
Clinical standards for drug-susceptible pulmonary TB
202214 citationsauthor #20
An All-Oral 6-Month Regimen for Multidrug-Resistant TB (the NExT Study): A Multicenter, Randomized Controlled Trial.
202237 citationsauthor #24
Efficacy of the AZD1222 (ChAdOx1 nCoV-19) COVID-19 Vaccine Against SARS-CoV-2 Variants of Concern
20222 citationsauthor #8
Durability of ChAdOx1 nCoV-19 (AZD1222) Vaccine and Hybrid Humoral Immunity Against Variants Including Omicron BA.1 and BA.4 Six Months after Vaccination: A Randomised, Phase 1b/2a Trial
20220 citationsauthor #9
Comparison of treatment outcome definitions in drug-resistant tuberculosis patients with high incidence of acquired second-line drug resistance
20223 citationsauthor #3
Accelerate investment and action to find the missing patients with tuberculosis
20224 citationsauthor #1
A revolution in the management of multidrug-resistant tuberculosis.
20226 citationsauthor #1
Treatment Response in Pediatric Pulmonary Tuberculosis-A Prospective Longitudinal Study.
20220 citationsauthor #5
The intersecting pandemics of tuberculosis and COVID-19: population-level and patient-level impact, clinical presentation, and corrective interventions
2022211 citationsauthor #1
Immunogenicity and safety of a SARS-CoV-2 recombinant spike protein nanoparticle vaccine in people living with and without HIV-1 infection: a randomised, controlled, phase 2A/2B trial
202252 citationsauthor #19
Transmission, distribution and drug resistance-conferring mutations of extensively drug-resistant tuberculosis in the Western Cape Province, South Africa
202212 citationsauthor #8
Position statement on endoscopic lung volume reduction in South Africa: 2022 update
20220 citationsauthor #3
Diagnostic accuracy of chest X-ray interpretation for tuberculosis by three artificial intelligence-based software in a screening use-case: an individual patient meta-analysis of global data
202220 citationsauthor #16
Durability of ChAdOx1 nCoV-19 (AZD1222) vaccine and hybrid humoral immunity against variants including omicron BA.1 and BA.4 6 months after vaccination (COV005): a post-hoc analysis of a randomised, phase 1b–2a trial
202220 citationsauthor #9
High mortality among patients hospitalized for drug‐resistant tuberculosis with acquired second‐line drug resistance and high HIV prevalence
20228 citationsauthor #5
Diagnostic Yield of Urine Lipoarabinomannan and Sputum Tuberculosis Tests in People Living with HIV: A Systematic Review and Meta-Analysis of Individual Participant Data
20221 citationsauthor #28
The impact of enteral feeding and therapeutic monitoring of rifampicin with dose-escalation in critically ill patients with tuberculosis.
202210 citationsauthor #11
Outcomes of patients undergoing lung resection for drug-resistant TB and the prognostic significance of pre-operative positron emission tomography/computed tomography (PET/CT) in predicting treatment failure
20223 citationsauthor #14
Clinical standards for the dosing and management of TB drugs
202251 citationsauthor #21
A breath of relief: High-flow nasal oxygen in a resource-limited setting
20220 citationsauthor #4
Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in people living with and without HIV in South Africa: an interim analysis of a randomised, double-blind, placebo-controlled, phase 1B/2A trial
2021107 citationsauthor #8
Impact of a personalised, digital, HIV self-testing app-based program on linkages and new infections in the township populations of South Africa
202130 citationsauthor #14
Profiles of Volatile Biomarkers Detect Tuberculosis from Skin (Adv. Sci. 15/2021)
20212 citationsauthor #12
Guidelines for the management of asthma in adults and adolescents: Position statement of the South African Thoracic Society – 2021 update
20218 citationsauthor #4
Moments of Uncertainty
20210 citationsauthor #5
Screening for Tuberculosis in Migrants: A Survey by the Global Tuberculosis Network
202112 citationsauthor #19
Pretomanid with bedaquiline and linezolid for drug-resistant TB: a comparison of prospective cohorts
202127 citationsauthor #17
An All-Oral 6-Month Regimen for Multi-Drug Resistant/Rifampicin-Resistant Tuberculosis: A Multi-Centre, Phase 3, Open Label, Randomised Controlled Trial (NeXT Study)
20211 citationsauthor #1
Chest X-ray Analysis With Deep Learning-Based Software as a Triage Test for Pulmonary Tuberculosis: An Individual Patient Data Meta-Analysis of Diagnostic Accuracy
202153 citationsauthor #6
A position statement and practical guide to the use of particulate filtering facepiece respirators (N95, FFP2, or equivalent) for South African health workers exposed to respiratory pathogens including Mycobacterium tuberculosis and SARS-CoV-2
20215 citationsauthor #1
Single Dose Administration, And The Influence Of The Timing Of The Booster Dose On Immunogenicity and Efficacy Of ChAdOx1 nCoV-19 (AZD1222) Vaccine
202130 citationsauthor #18
Efficacy of the NVX-CoV2373 Covid-19 Vaccine Against the B.1.351 Variant
2021181 citationsauthor #16
A position statement and practical guide to the use of particulate filtering facepiece (N95, FFP2, or equivalent) respirators for South African health care workers exposed to respiratory pathogens including M. tuberculosis and SARS-CoV-2
20211 citationsauthor #1
Moments of Uncertainty: Exploring How an App-Based Oral HIV Self-Testing Strategy Fits in Communities ‘Living Under’ HIV Risk
20216 citationsauthor #5
Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant
20211,101 citationsauthor #8
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials.
20211,038 citationsauthor #18
Evolution of SARS-CoV-2 mutational variants: Hysteria or hope for the future?
20210 citationsauthor #3

TIMELINE

1936 92 citations

1981 38 citations

2002 217 citations

2004 1,557 citations

2005 3,634 citations

2006 831 citations

2007 398 citations

2008 313 citations

2009 1,306 citations

2010 3,412 citations

2011 2,057 citations

2012 1,205 citations

2013 1,825 citations

2014 2,290 citations

2015 614 citations

2016 1,066 citations

2017 2,248 citations

2018 2,437 citations

2019 1,330 citations

2020 4,517 citations

2021 3,012 citations

2022 488 citations

2023 447 citations

2024 209 citations

2025 18 citations

2026 0 citations

Unknown 0 citations

K. Dheda

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT